14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis AI Analysis of PACB
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

High volatility in Pacific Biosciences of California stock price on Friday which ended trading at $1.98
(Updated on Oct 11, 2024)

Buy candidate since Oct 11, 2024

The Pacific Biosciences of California stock price gained 27.74% on the last trading day (Friday, 11th Oct 2024), rising from $1.55 to $1.98. During the last trading day the stock fluctuated 32.26% from a day low at $1.55 to a day high of $2.05. The price has fallen in 7 of the last 10 days but is still up by 13.14% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 15 million more shares were traded than the day before. In total, 24 million shares were bought and sold for approximately $47.93 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.06 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -5.49% during the next 3 months and, with a 90% probability hold a price between $1.20 and $1.95 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PACB Signals & Forecast

The Pacific Biosciences of California stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.70 and $1.66. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, October 10, 2024, and so far it has risen 27.74%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Pacific Biosciences of California stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.74 and $1.67. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pacific Biosciences of California finds support just below today's level at $1.74. If this is broken, then the next support from accumulated volume will be at $1.67 and $1.60.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.500 between high and low, or 32.26%. For the last week, the stock has had daily average volatility of 12.33%.

Our recommended stop-loss: $1.90 (-3.80%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (PACB) For The Upcoming Trading Day Of Monday 14th

For the upcoming trading day on Monday, 14th we expect Pacific Biosciences of California to open at $1.86, and during the day (based on 14 day Average True Range), to move between $1.81 and $2.15, which gives a possible trading interval of +/-$0.170 (+/-8.61%) up or down from last closing price. If Pacific Biosciences of California takes out the full calculated possible swing range there will be an estimated 17.22% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.05 (3.54%) than the support at $1.74 (12.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pacific Biosciences of California stock A Buy?

Pacific Biosciences of California holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect Pacific Biosciences of California stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Buy candidate.

Current score: 5.289 Strong Buy Candidate Upgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on October 14, 2024 - $1.86 ( 6.06%). The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PACB

Fibonacci Support & Resistance Levels

Level Price
R3 2.36 19.19%
R2 2.17 9.55%
R1 2.05 3.59%
Price 1.98
S1 1.67 -15.71%
S2 1.55 -21.67%
S3 1.36 -31.31%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.18 9.85%
R2 2.14 7.83%
R1 2.05 3.54%
Price 1.98
S1 1.74 -12.12%
S2 1.67 -15.66%
S3 1.60 -19.19%

FAQ

What is the symbol for Pacific Biosciences of California Stock and on which exchange is it traded?
The symbol for Pacific Biosciences of California is PACB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pacific Biosciences of California Stock?
Pacific Biosciences of California holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect Pacific Biosciences of California stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Buy candidate.

How to buy Pacific Biosciences of California Stock?
Pacific Biosciences of California Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pacific Biosciences of California Stock.

What's the current price of Pacific Biosciences of California Stock?
As of the end of day on the Oct 11, 2024, the price of an Pacific Biosciences of California (PACB) share was $1.98.

What is the 52-week high and low for Pacific Biosciences of California Stock?
The 52-week high for Pacific Biosciences of California Stock is $10.65 and the 52-week low is $1.16.

What is the market capitalization of Pacific Biosciences of California Stock?
As of the Oct 11, 2024, the market capitalization of Pacific Biosciences of California is 438.772M.

When is the next earnings date for Pacific Biosciences of California?
The upcoming earnings date for Pacific Biosciences of California is Nov 04, 2024.
Click to get the best stock tips daily for free!
ABOUT PACIFIC BIOSCIENCES OF CALIFORNIA
Pacific Biosciences of California
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded...
GOLDEN STAR
Ticker Change Signal Date
SUN
$53.12
1.20% Oct 09
BRK-B
$455.90
0.95% Oct 09
ESGR
$321.00
0.732% Oct 09
WTRG
$38.60
1.45% Oct 09
VNT
$33.53
2.92% Oct 09

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE